ATE529116T1 - Verfahren zur verstärkung des therapeutischen ansprechens auf elektrokonvulsive therapie (ect) - Google Patents
Verfahren zur verstärkung des therapeutischen ansprechens auf elektrokonvulsive therapie (ect)Info
- Publication number
- ATE529116T1 ATE529116T1 AT03726554T AT03726554T ATE529116T1 AT E529116 T1 ATE529116 T1 AT E529116T1 AT 03726554 T AT03726554 T AT 03726554T AT 03726554 T AT03726554 T AT 03726554T AT E529116 T1 ATE529116 T1 AT E529116T1
- Authority
- AT
- Austria
- Prior art keywords
- ect
- therapeutic response
- enhancement
- electroconvulsive therapy
- electroconvulsive
- Prior art date
Links
- 238000002635 electroconvulsive therapy Methods 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 230000004797 therapeutic response Effects 0.000 title abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- 102000003676 Glucocorticoid Receptors Human genes 0.000 abstract 1
- 108090000079 Glucocorticoid Receptors Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37681402P | 2002-04-29 | 2002-04-29 | |
| US10/411,503 US7326697B2 (en) | 2002-04-29 | 2003-04-08 | Methods for increasing the therapeutic response to electroconvulsive therapy |
| PCT/US2003/013498 WO2003092790A2 (en) | 2002-04-29 | 2003-04-28 | Methods for increasing the therapeutic response to electroconvulsive therapy ('ect') |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE529116T1 true ATE529116T1 (de) | 2011-11-15 |
Family
ID=29406770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03726554T ATE529116T1 (de) | 2002-04-29 | 2003-04-28 | Verfahren zur verstärkung des therapeutischen ansprechens auf elektrokonvulsive therapie (ect) |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7326697B2 (de) |
| EP (1) | EP1499321B1 (de) |
| JP (2) | JP2005526843A (de) |
| KR (1) | KR100970834B1 (de) |
| CN (1) | CN100438875C (de) |
| AT (1) | ATE529116T1 (de) |
| AU (1) | AU2003228783B2 (de) |
| CA (1) | CA2483855C (de) |
| ES (1) | ES2375356T3 (de) |
| IL (2) | IL164793A0 (de) |
| MX (1) | MXPA04010705A (de) |
| NO (1) | NO335006B1 (de) |
| NZ (1) | NZ536248A (de) |
| PT (1) | PT1499321E (de) |
| WO (1) | WO2003092790A2 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
| US8097606B2 (en) | 2003-07-23 | 2012-01-17 | Corcept Therapeutics, Inc. | Antiglucocorticoids for the treatment of catatonia |
| US7747324B2 (en) * | 2005-11-10 | 2010-06-29 | Electrocore Llc | Electrical stimulation treatment of bronchial constriction |
| US8812112B2 (en) * | 2005-11-10 | 2014-08-19 | ElectroCore, LLC | Electrical treatment of bronchial constriction |
| US20110125203A1 (en) * | 2009-03-20 | 2011-05-26 | ElectroCore, LLC. | Magnetic Stimulation Devices and Methods of Therapy |
| US9037247B2 (en) | 2005-11-10 | 2015-05-19 | ElectroCore, LLC | Non-invasive treatment of bronchial constriction |
| US8041428B2 (en) | 2006-02-10 | 2011-10-18 | Electrocore Llc | Electrical stimulation treatment of hypotension |
| WO2007094828A2 (en) | 2006-02-10 | 2007-08-23 | Electrocore, Inc. | Electrical stimulation treatment of hypotension |
| US7711430B2 (en) | 2006-02-10 | 2010-05-04 | Electrocore Llc | Methods and apparatus for treating anaphylaxis using electrical modulation |
| US20100241188A1 (en) * | 2009-03-20 | 2010-09-23 | Electrocore, Inc. | Percutaneous Electrical Treatment Of Tissue |
| EP1987814A1 (de) * | 2007-04-30 | 2008-11-05 | Exelgyn | Pharmazeutische Mifepristonzusammensetzungen und Herstellungsverfahren dafür |
| US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
| KR101719824B1 (ko) | 2008-05-09 | 2017-04-04 | 호라이라 인코포레이티드 | 기관지나무 치료용 시스템, 어셈블리 및 방법 |
| CN107049479B (zh) | 2009-10-27 | 2020-10-16 | 努瓦拉公司 | 具有可冷却的能量发射组件的递送装置 |
| US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
| CN106618731B (zh) | 2009-11-11 | 2020-08-07 | 努瓦拉公司 | 用于处理组织和控制狭窄的系统、装置和方法 |
| EP2701744A4 (de) * | 2011-03-23 | 2014-08-20 | Pop Test Cortisol Llc | Kombinationstherapie |
| US10500216B2 (en) | 2011-11-18 | 2019-12-10 | Corcept Therapeutics, Inc. | Optimizing mifepristone absorption |
| US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
| US9943526B2 (en) | 2015-04-21 | 2018-04-17 | Corcept Therapeutics, Inc. | Optimizing mifepristone levels for cushing's patients |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4296206A (en) | 1980-04-30 | 1981-10-20 | United States Of America | Irreversible anti-glucocorticoids |
| ZA8231B (en) | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
| FR2598421B1 (fr) | 1986-05-06 | 1988-08-19 | Roussel Uclaf | Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant |
| US4873981A (en) | 1988-10-14 | 1989-10-17 | Somatics, Inc. | Electroconvulsive therapy apparatus and method for automatic monitoring of patient seizures |
| FR2757400B1 (fr) * | 1996-12-19 | 1999-12-17 | Hoechst Marion Roussel Inc | Application des composes antiglucocorticoides dans le traitement des psychoses ou des comportements addictifs |
| ATE332696T1 (de) * | 1997-10-06 | 2006-08-15 | Univ Leland Stanford Junior | Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen |
| NZ507449A (en) | 1998-05-15 | 2003-08-29 | Univ Leland Stanford Junior | Glucocorticoid receptor antagonists for the treatment of dementia |
| JP4528629B2 (ja) * | 2002-12-18 | 2010-08-18 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | ワークピースを備えた被駆動部材に駆動部材を含む器具を着脱可能に接続するためのシステム |
-
2003
- 2003-04-08 US US10/411,503 patent/US7326697B2/en not_active Expired - Lifetime
- 2003-04-28 EP EP03726554A patent/EP1499321B1/de not_active Expired - Lifetime
- 2003-04-28 WO PCT/US2003/013498 patent/WO2003092790A2/en not_active Ceased
- 2003-04-28 MX MXPA04010705A patent/MXPA04010705A/es active IP Right Grant
- 2003-04-28 PT PT03726554T patent/PT1499321E/pt unknown
- 2003-04-28 CA CA2483855A patent/CA2483855C/en not_active Expired - Fee Related
- 2003-04-28 JP JP2004500971A patent/JP2005526843A/ja not_active Withdrawn
- 2003-04-28 ES ES03726554T patent/ES2375356T3/es not_active Expired - Lifetime
- 2003-04-28 CN CNB038133318A patent/CN100438875C/zh not_active Expired - Fee Related
- 2003-04-28 KR KR1020047017463A patent/KR100970834B1/ko not_active Expired - Fee Related
- 2003-04-28 AT AT03726554T patent/ATE529116T1/de active
- 2003-04-28 NZ NZ536248A patent/NZ536248A/en not_active IP Right Cessation
- 2003-04-28 AU AU2003228783A patent/AU2003228783B2/en not_active Ceased
- 2003-04-28 IL IL16479303A patent/IL164793A0/xx unknown
-
2004
- 2004-10-24 IL IL164793A patent/IL164793A/en active IP Right Grant
- 2004-11-29 NO NO20045232A patent/NO335006B1/no not_active IP Right Cessation
-
2011
- 2011-03-02 JP JP2011045207A patent/JP2011116771A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1499321A2 (de) | 2005-01-26 |
| IL164793A (en) | 2012-02-29 |
| HK1068783A1 (en) | 2005-05-06 |
| JP2005526843A (ja) | 2005-09-08 |
| KR100970834B1 (ko) | 2010-07-16 |
| PT1499321E (pt) | 2012-02-01 |
| EP1499321A4 (de) | 2008-09-03 |
| WO2003092790A2 (en) | 2003-11-13 |
| CA2483855A1 (en) | 2003-11-13 |
| AU2003228783C1 (en) | 2003-11-17 |
| NO335006B1 (no) | 2014-08-25 |
| MXPA04010705A (es) | 2005-02-17 |
| EP1499321B1 (de) | 2011-10-19 |
| WO2003092790A3 (en) | 2003-12-11 |
| JP2011116771A (ja) | 2011-06-16 |
| CA2483855C (en) | 2012-01-10 |
| NO20045232L (no) | 2005-01-26 |
| IL164793A0 (en) | 2005-12-18 |
| US7326697B2 (en) | 2008-02-05 |
| CN1658883A (zh) | 2005-08-24 |
| KR20040105247A (ko) | 2004-12-14 |
| US20040029849A1 (en) | 2004-02-12 |
| ES2375356T3 (es) | 2012-02-29 |
| CN100438875C (zh) | 2008-12-03 |
| NZ536248A (en) | 2007-03-30 |
| AU2003228783A1 (en) | 2003-11-17 |
| AU2003228783B2 (en) | 2006-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE529116T1 (de) | Verfahren zur verstärkung des therapeutischen ansprechens auf elektrokonvulsive therapie (ect) | |
| TW200510416A (en) | P38 inhibitors and methods of use thereof | |
| ATE451376T1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
| DE602005023763D1 (de) | Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine | |
| TNSN07161A1 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| DE69835225D1 (de) | Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen | |
| MY169308A (en) | Treatment of tnf? related disorders | |
| EA200700097A1 (ru) | Производные хиназолин-4-илпиперидина и циннолин-4-илпиперидина в качестве ингибиторов pde10 для лечения расстройств цнс | |
| ATE450251T1 (de) | Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung | |
| DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| ATE464303T1 (de) | Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen | |
| ECSP045520A (es) | Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos | |
| TW200630090A (en) | Triazoles useful as inhibitors of protein kinases | |
| DE602004012578D1 (de) | Als inhibitoren von c-met geeignete pyrrolzusammensetzungen | |
| DK1315506T3 (da) | Phospholipidderivater af valproinsyre og blandinger deraf | |
| DE60228073D1 (de) | Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen | |
| ATE317699T1 (de) | Glucocorticoid receptor antagonisten zur behandlung von demenz | |
| TW200621244A (en) | Modulators of muscarinic receptors | |
| ATE279208T1 (de) | Verfahren und stoffe zur behandlung des prostatakarzinomes | |
| ATE302002T1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
| NO20065297L (no) | Anvendelse av GPCR54 ligander til behandling av infertilitet | |
| ATE522230T1 (de) | Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit | |
| MXPA05011699A (es) | Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior. | |
| MXPA05008347A (es) | Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis. | |
| DE59809283D1 (de) | Inhibitoren für den urokinaserezeptor |